6 results on '"Neurofibromatosis Type 1"'
Search Results
2. Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.
- Author
-
Yamauchi T and Suka M
- Subjects
- Female, Humans, Male, Middle Aged, Depression, Japan epidemiology, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Adult, Neurofibromatosis 1 epidemiology, Neurofibromatosis 1 complications, Neurofibromatosis 1 pathology
- Abstract
Background: This study examined the association between dermatological, neurological, and bone manifestations of neurofibromatosis type 1 (NF1) and quality of life (QoL) in patients with NF1 using a nationwide database of all patients who newly claimed for medical expense subsidies in Japan from 2015 to 2019., Methods: The Japanese Ministry of Health, Labour and Welfare provided the "National Database of Designated Intractable Diseases of Japan" containing clinical and personal records ("Medical Certificates of Designated Intractable Diseases") of all patients with NF1 following approval of the study protocol. To examine the association between the severity of symptoms and QoL, multinominal logistic regression analyses were performed, adjusted for potential confounders., Results: The final study population consisted of 1,487 patients (775 females and 712 males; mean (standard deviation) age, 45.4 (17.9) years). More than 50% and nearly 45% of participants were recorded as having moderate or severe "pain/discomfort" and "anxiety/depression," respectively. The severity of neurological symptoms was significantly associated with all components of QoL, whereas the severity of dermatological symptoms was significantly associated with only moderate or severe subjective and mental health-related components of QoL, and the severity of bone lesions was associated with only moderate or severe physical health-related components of QoL. Subjective and mental health-related components of QoL tended to be deteriorated more than physical health-related components of QoL in younger and female patients., Conclusions: Severities of neurological and dermatological symptoms were significantly associated with subjective and mental health-related components of QoL, while the severity of bone symptoms was associated with only moderate and severe deterioration of physical health-related components of QoL.
- Published
- 2023
- Full Text
- View/download PDF
3. Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.
- Author
-
Yamauchi, Takashi, Suka, Machi, Nishigori, Chikako, and Yanagisawa, Hiroyuki
- Subjects
- *
NEUROFIBROMATOSIS 1 , *MEDICAL care costs , *MEDICAL registries , *SUBSIDIES , *AGE groups , *RARE diseases - Abstract
Background: No study to date has followed disease progression in patients with neurofibromatosis type 1 (NF1), including the incidence of various manifestations, using a national registry. Here we examined the state of NF1 progression using a nationwide registry of patients who submitted claims to receive medical expense subsidies for NF1 in Japan over a five-year period. A total of 342 eligible patients (194 females and 148 males) with NF1 who newly submitted claims for medical expense subsidies in Japan in 2008 were followed until 2012.Results: More than half of the patients were classified as Stage 5 in 2008. Of the eligible patients, 205 (60%) submitted claims to renew the subsidies between 2009 and 2012. During the study period, NF1 stage progressed in 30 patients, yielding an overall stage progression rate of 19% and progression incidence rate per 100 person-years of 12.2. Both stage progression rate and progression incidence rate were the highest in the 0-19 year age group at the time of registration and, as compared to other age groups, progression of neurological and bone manifestations was more prevalent in this age group.Conclusions: The progression of neurological and bone manifestations was more prevalent in the 0-19 year age group compared to other age groups. The registry we used in the present study is useful for understanding the characteristics of patients with uncommon conditions, such as NF1. Our findings also highlight the feasibility of conducting quality research using registries of patients with rare diseases, such as NF1, that were not designed specifically for scientific research. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
4. Legius syndrome: A case report.
- Author
-
Kimura R, Yoshida Y, Maruoka R, Kosaki K, and Yamamoto O
- Subjects
- Adaptor Proteins, Signal Transducing, Adult, Cafe-au-Lait Spots blood, Codon, Nonsense, Diagnosis, Differential, Exons genetics, Female, High-Throughput Nucleotide Sequencing, Humans, Japan, Melanosis genetics, Rare Diseases blood, Sequence Analysis, DNA, Cafe-au-Lait Spots diagnosis, Cafe-au-Lait Spots genetics, Intracellular Signaling Peptides and Proteins genetics, Membrane Proteins genetics, Neurofibromatosis 1 diagnosis, Rare Diseases diagnosis, Rare Diseases genetics
- Abstract
Legius syndrome is a rare genetic disorder caused by heterozygous germ line loss-of-function SPRED1 mutation. In Japan, a family with Legius syndrome was first described in 2015 by Sakai et al. We described a first solitary case of Legius syndrome identified by next-generation sequencing in Japan. A 37-year-old woman presented with multiple café-au-lait macules and freckles but has no other features of neurofibromatosis type 1 (NF-1). Sequencing results showed the presence of a mutation in exon 2 of SPRED1 c.70C>T, resulting in the protein at position 24 (p.Arg24X). When a dermatological clinician sees an adult patient showing only pigmented lesions and no other specifically diagnostic features of NF-1, it is important to suspect the possibility of Legius syndrome., (© 2016 Japanese Dermatological Association.)
- Published
- 2017
- Full Text
- View/download PDF
5. Development of a practical NF1 genetic testing method through the pilot analysis of five Japanese families with neurofibromatosis type 1.
- Author
-
Okumura A, Ozaki M, and Niida Y
- Subjects
- Adolescent, Adult, Asian People, Child, Child, Preschool, Codon, Nonsense, Electrophoresis, Polyacrylamide Gel methods, Female, Humans, Japan, Male, Mutation, Missense, Oligonucleotide Array Sequence Analysis, Pilot Projects, Point Mutation, Reverse Transcriptase Polymerase Chain Reaction methods, Silver Staining methods, Young Adult, Genetic Testing methods, Mutation, Neurofibromatosis 1 diagnosis, Neurofibromatosis 1 genetics
- Abstract
Objective: Mutation analysis of NF1, the responsible gene for neurofibromatosis type 1 (NF1), is still difficult due to its large size, lack of mutational hotspots, the presence of many pseudogenes, and its wide spectrum of mutations. To develop a simple and inexpensive NF1 genetic testing for clinical use, we analyzed five Japanese families with NF1 as a pilot study., Methods: Our original method, CEL endonuclease mediated heteroduplex incision with polyacrylamide gel electrophoresis and silver staining (CHIPS) was optimized for NF1 mutation screening, and reverse transcription polymerase chain reaction (RT-PCR) was performed to determine the effect of transcription. Also, we employed DNA microarray analysis to evaluate the break points of the large deletion., Results: A new nonsense mutation, p.Gln209(∗), was detected in family 1 and the splicing donor site mutation, c.2850+1G>T, was detected in family 2. In family 3, c.4402A>G was detected in exon 34 and the p.Ser1468Gly missense mutation was predicted. However mRNA analysis revealed that this substitution created an aberrant splicing acceptor site, thereby causing the p.Phe1457(∗) nonsense mutation. In the other two families, type-1 and unique NF1 microdeletions were detected by DNA microarray analysis., Conclusions: Our results show that the combination of CHIPS and RT-PCR effectively screen and characterize NF1 point mutations, and both DNA and RNA level analysis are required to understand the nature of the NF1 mutation. Our results also suggest the possibility of a higher incidence and unique profile of NF1 large deletions in the Japanese population as compared to previous studies performed in Europe., (Copyright © 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
6. Anthropometric characteristics and comorbidities in Japanese patients with neurofibromatosis type 1: a single institutional case-control study.
- Author
-
Koga M, Koga K, Nakayama J, and Imafuku S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Asian People genetics, Body Height, Body Mass Index, Child, Child, Preschool, Comorbidity, Female, Heart Valve Diseases genetics, Humans, Infant, Infant, Newborn, Japan epidemiology, Male, Middle Aged, Neurofibromatosis 1 immunology, Retrospective Studies, Thyroid Diseases genetics, Young Adult, Hypersensitivity genetics, Neurofibromatosis 1 epidemiology
- Abstract
Neurofibromatosis type 1 (NF1) is a well-known genetic disorder characterized by café-au-lait spots and neurofibromas, but many other clinical characteristics and associated comorbidities also have been reported. This study aimed to characterize NF1 further by investigating its association with anthropometric characteristics and other diseases. We performed a case-control study of 227 NF1 patients (101 male, 126 female) and a randomly selected age- and sex-matched control group of 681 non-NF1 patients (303 male, 378 female) who visited our institution in Japan. We examined adult (≥20 years) height and body mass index (BMI), and, in the total sample, allergic diseases (bronchial asthma [BA], atopic dermatitis [AD] and allergic rhinitis) and other respiratory cardiovascular and psychiatric disorders. In adults, the mean BMI was lower in the NF1 group than in the control group, and was significantly statistically different among men (P = 0.0238). In the whole sample, the prevalences of BA (P = 0.0184), AD (P = 0.0144) and valvular heart disease (P = 0.0166) were significantly greater in the NF1 group than in the control group. To date, no similar research on the BMI or the prevalence of allergic disease in NF1 patients has been reported. Our results suggest that NF1 patients tend to have lower BMI and may have alterations in specific metabolic pathways and altered allergic immunity., (© 2014 Japanese Dermatological Association.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.